The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Clinical SynthesisFull Access

Evidence-Based Psychotherapy for Eating Disorders

Abstract

Recommended psychotherapies for treating bulimia nervosa and binge eating disorder have been clearly established, with cognitive-behavioral therapy representing the leading choice. Second line psychotherapies for bulimia nervosa and binge eating disorder are interpersonal psychotherapy, as well as dialectical behavior therapy for bulimia nervosa and behavioral weight loss for binge eating disorder. An urgent need remains for effective and acceptable treatments for anorexia nervosa among adults with the choice of treatment currently informed by an array of psychotherapies with weak efficacy; trends toward high treatment drop out and poor adherence are important issues to resolve. Among children and adolescents with anorexia nervosa, and to some extent bulimia nervosa, family-based treatments that directly target eating are favored. Pharmacotherapy may also be recommended for some individuals with eating disorders, which would be administered by a primary care practitioner or psychiatrist for more severe, chronic cases or cases in which considerable psychiatric comorbidity is present. Treatment for eating disorders commonly involves a collaborative health care team that includes a psychotherapist and psychiatrist along with a primary care practitioner for regular monitoring of physical state.

Evidence-Based Psychotherapy for Eating Disorders

Clinical Context

According to the Diagnostic and Statistical Manual, Fourth Edition (DSM-IV) (1), lifetime prevalence estimates for eating disorders in the United States are: 0.9% for anorexia nervosa, 1.5% for bulimia nervosa, and 3.5% for binge eating disorder among women; and 0.3% for anorexia nervosa, 0.5% for bulimia nervosa, and 2.0% for binge eating disorder among men (2). The onset of eating disorders is typically in adolescence, with puberty a critical risk period, but the disorders may occur in patients as young as 7 and as old as 70 years or more (3). Eating disorders can have substantial and sustained physical consequences, comorbidity, mortality, chronicity, and functional impairment (4, 5).

The Diagnostic and Statistical Manual (DSM-5) (6) groups together eating and feeding disorders; here we cover the eating disorder diagnoses anorexia nervosa, bulimia nervosa, binge eating disorder, and other specified feeding and eating disorders. The diagnostic criteria are outlined in Table 1. Eating disorders involve dysregulated eating habits such as a restriction of intake below energy needs, omitting entire food groups (e.g., fats or carbohydrates), calorie counting, skipping meals, and fasting. For some there is a cyclic pattern of restricting, which brings on the body’s starvation response, triggers binge eating, and then leads to further restricting and compensatory behaviors to neutralize the calories consumed. Binge eating is similar to overeating in that both involve consuming an unusually large amount of food in a discrete period of time, but binge eating is distinguished by the accompanying sense of loss of control (i.e., feeling unable to stop eating). Compensatory behaviors include purging (self-induced vomiting, laxatives, and diuretics), fasting, and compulsive exercise.

Table 1. Summary of DSM–5 Eating Disorder Diagnoses

DiagnosisKey features
Anorexia nervosa
Significantly low body weight due to persistent restriction of energy intake, fear of gaining weight or becoming fat, or enduring behavior that prevents weight gain, and body image disturbance.
Bulimia nervosa
Objective binge eating plus inappropriate compensatory behaviors to prevent weight gain (e.g., self-induced vomiting, fasting, excessive exercise) that recur on average more than or at least once per week for 3 months.
Binge eating disorder
Binge eating associated with feeling embarrassed, depressed, or guilty afterward, and marked distress regarding the binge episode that recurs more than or at least once per week for 3 months with no recurrent use of inappropriate compensatory behaviors.
Other specified feeding or eating disorders
Atypical anorexia nervosa: individual’s weight is within or above the normal range (although significant weight loss has occurred);
Bulimia nervosa (of low frequency and/or limited duration);
Binge eating disorder (of low frequency and/or limited duration);
Purging disorder: purging behavior to influence weight or shape while no binge eating is present;
Night eating syndrome: episodes of eating after awakening from sleep, or by consumption of high amounts of food after the evening meal.
Unspecified feeding or eating disorderEating-related behaviors causing clinically significant distress while full criteria for any of the feeding or eating disorders are not met.

Table 1. Summary of DSM–5 Eating Disorder Diagnoses

Enlarge table

Long-term medical complications of eating disorders are significant. Starvation and purging symptoms have the potential to deteriorate every major organ system in the body, leading to kidney damage, anemia, cardiovascular problems, dental problems, and changes in brain structure. Osteoporosis and osteopenia are irreversible consequences of malnutrition. Obesity is commonly associated with BED, but BED also occurs in normal weight individuals (7). Mortality and morbidity are elevated across all eating disorders (4, 8).

Psychotherapy for eating disorders may occur in a number of contexts. Some patients may do well with empirically supported self-help or outpatient psychotherapy. Others may require more intensive treatment in the form of day or partial hospitalization or intensive outpatient treatment, which may include structured meal support, family interventions, group psychotherapy, cooking and nutrition groups, and social skills interventions (9). Psychotherapy for anorexia nervosa may occur along with medical admissions for those patients who are acutely medically unwell and/or severely malnourished. Attempts to conduct formal psychotherapy when the patient is severely malnourished can be ineffective, because of mild cognitive impairment (10). Supportive psychotherapeutic interventions that provide empathy, support, and positive behavioral reinforcement may be more appropriate than more intensive psychotherapies until renourishment is well underway (10).

Treatment Strategies and Evidence

The “gold standard” method for evaluating the efficacy of psychotherapies is the randomized controlled trial (RCT). Yet, controlled trial research in anorexia nervosa and among children with eating disorders in general is hampered by methodological challenges. The acute prospect of mortality from anorexia nervosa and the long-term risks to growth and physical development in children preclude the use of a no-treatment or delayed treatment control group, complicating the evaluation of specific treatment effects (11). For anorexia nervosa, high treatment drop out (∼50%) can compromise randomization, and the egosyntonicity of the illness can lead to low treatment adherence. In some RCTs, uncontrolled background treatments (i.e., inpatient care) are present (12). To understand the current state of the evidence for psychotherapies in eating disorders, a multipronged approach that considers RCTs or other systematic research studies, clinical practice guidelines, and emerging interventions is worthwhile. This approach informs this review.

Adults

Anorexia Nervosa

There is no strong evidence for the efficacy of any psychotherapy or pharmacotherapy in the treatment of anorexia nervosa in adults. Clinical practice guidelines (13, 14) recommend considering cognitive-behavioral therapy (CBT), interpersonal psychotherapy (IPT), cognitive analytic therapy, and focal psychodynamic therapy, and regular physical monitoring by a primary care practitioner. These psychotherapies are the most well-evaluated and theoretically supported approaches. The RCT base is limited (11), and marred by small sample sizes, high drop out, short duration, lack of long-term follow-up, and other methodological issues.

Since the publication of clinical guidelines new data have been reported. A large, multicenter RCT compared 10 months of focal psychodynamic therapy, CBT enhanced (CBT-E), and optimized treatment-as-usual (15). At endpoint, intent-to-treat analysis showed significantly increased body mass index (BMI) in all groups and no treatment differences. At 12 month follow-up, BMI continued to improve but again, there were no differences by treatment. Thirty percent of the patients dropped out during treatment.

In addition, seven year follow-up data were reported from an RCT that compared CBT, IPT, and specialist supportive clinical management (16, 17). At treatment completion, a significantly greater number of patients who completed specialist supportive clinical management (36%) no longer met diagnostic criteria for anorexia nervosa, compared with 8% who completed CBT and 0% who completed IPT. In the intent-to-treat sample, 25% assigned to specialist supportive clinical management, 5% assigned to CBT, and 0% assigned to IPT no longer met diagnostic criteria at posttreatment (16). However, at 7-year follow-up there were no statistically significant differences between the treatments, with 64% in IPT, 42% in specialist supportive clinical management, and 41% in CBT no longer meeting diagnostic criteria (17).

Several large RCTs involving a range of psychotherapies are currently underway (see 11). Modalities under evaluation include CBT, couple-based CBT, exposure and response prevention, specialist supportive clinical management, focal psychodynamic therapy, and two relatively new interventions: cognitive remediation therapy and a social-cognitive interpersonal psychotherapy (MANTRA). Cognitive remediation therapy addresses neuropsychological mechanisms implicated in anorexia nervosa including rigidity and weak central coherence, and MANTRA targets intrapersonal and interpersonal processes that maintain anorexia nervosa by helping individuals to express and process emotions and social relationships.

Bulimia Nervosa and Binge Eating Disorder

First Line Psychotherapy

The first line treatment for adults with bulimia nervosa (or bulimia-like illnesses) is CBT designed specifically for bulimia nervosa (13, 14). CBT for bulimia was developed soon after bulimia nervosa entered the medical literature (18) and is time-limited with a duration of approximately 20 weekly sessions. CBT is also a first line approach for binge eating disorder (13, 14).

One CBT model for bulimia (18) proposes that the disorder is maintained by problems with self-esteem and extreme concerns about shape and weight. These interact to produce strict dieting, binge eating, and compensatory behaviors, which become part of a self-perpetuating vicious cycle. In some individuals, binge eating emerges in rebound from restrictive eating; in others, binge eating arises in the absence of dieting or dietary restraint. CBT addresses cognitive, emotional, and behavioral factors that maintain the disorder. A key first step is the normalization of meals and snacks, which offsets the likelihood of a binge episode, in turn reducing the use of compensatory behaviors. The model has been extended to binge eating disorder (19) with the normalization of eating patterns aimed at countering both restriction and binge eating.

The research supporting a CBT treatment approach is robust (20, 21), hence it is recommended in clinical practice guidelines around the world as the leading treatment for bulimia nervosa (10, 13). On average, approximately 50% of patients with bulimia who undergo a course of CBT attain binge-purge abstinence (22). Treatment normally lasts 12 to 20 sessions held over 3 to 5 months. Antidepressant medication may be an alternative or additional first step (13). Fluoxetine for bulimia nervosa is the only Food and Drug Administration-approved medication for any eating disorder, and although it is effective at reducing binge eating in the short run, it is of unknown long-term efficacy as a sole treatment (23). Guided self-help and pure self-help CBT for bulimia nervosa are also effective in reducing the frequency of binge eating and purging but may be less effective in achieving abstinence from these behaviors than face-to-face psychotherapy (24). Empirically supported self-help is recommended for use in a stepped care approach or when standard CBT is inaccessible.

CBT for binge eating disorder has been tested in individual, group, and self-help formats (25) and is recognized in guidelines as the first line approach (13, 14). Remission rates for binge eating at posttreatment are around 50% (26). In the United Kingdom, self-help is recommended as the first line approach in the treatment of binge eating disorder (13). Pharmacotherapy may also play a role in the treatment of binge eating disorder. Classes of medications showing some efficacy include antidepressants, anticonvulsants, and antiobesity agents (25).

CBT has been recast by Fairburn (27) to apply to all eating disorders (CBT-E) and to address additional maintaining factors (perfectionism, mood intolerance, core low self-esteem, and interpersonal difficulties).

Second Line Psychotherapies

IPT is recommended as a second line approach in the National Institutes of Health and Clinical Excellence and American Psychiatric Association practice guidelines (13, 14). IPT was originally developed in the 1960s for the treatment of unipolar depression, and was adapted for bulimia nervosa in the late 1980s (28) and for binge eating disorder in the 1990s (29). For individuals with bulimia nervosa and binge eating disorder who complete treatment, binge (and purge) abstinence rates are around 50% (30). The IPT model posits that difficulties in interpersonal relationships and functioning contribute to the development and maintenance of psychiatric symptoms. The treatment is time-limited (approximately 20 weekly sessions) and involves three phases: assessment of the interpersonal issues affecting the patient’s symptoms, therapeutic work to help the patient make interpersonal changes in one or more of four IPT areas of role disputes, role transitions, interpersonal deficits, unresolved grief, and last, a termination phase. IPT for bulimia nervosa demonstrates equivalent outcomes to CBT at longer-term follow-up, but achieves its effects less rapidly (21, 30). In a large multicenter trial of CBT and IPT for bulimia nervosa (30), binge eating and purging abstinence in the intent-to-treat sample was 29% for CBT and 6% for IPT at posttreatment, and 22% for CBT and 18% for IPT at 4 month follow-up. Regarding binge eating disorder, the first line of treatment is CBT in a self-help form with direct support from a health professional, followed by standard CBT if self-help is declined. If the illness persists, IPT or dialectical behavior therapy (DBT) modified for binge eating disorder are treatments to consider.

DBT has been less extensively evaluated for bulimia nervosa and binge eating disorder than CBT, but has demonstrated efficacy. DBT acts on the patient’s emotion regulation skills, with the goal of improving coping with emotional distress so that binging and purging are reduced. Treatment is adapted from Linehan’s DBT protocol for borderline personality disorder (31, 32) and detailed in a manual (33), which recommends 20 weekly sessions. DBT has been evaluated among individuals with binge eating disorder in two RCTs, in a group format. In the first, DBT was superior to wait-list, with 89% binge abstinent at posttreatment compared with 12.5% for wait-list, and 56% in the DBT group abstinent at 6-month follow-up (34). The second trial found that DBT was superior to a nonspecific control at posttreatment (64% versus 36%), but there was no difference at 12-month follow-up (64% versus 56%) (35).

A behavioral weight loss (BWL) intervention widely used in obesity RCTs and empirically supported as a self-help intervention for obesity (36) has been tested for efficacy among overweight and obese individuals with binge eating disorder. It has been effective in reducing binge eating and eating pathology, however, CBT and IPT have been shown to be more effective in addressing core eating pathology (37). The BWL intervention involves lifestyle changes in exercise and nutrition with a focus on increased physical activity and moderate caloric restriction to produce gradual, modest weight loss. The intervention lasts for 12 weeks.

Other Eating Disorders

Expert consensus suggests that to manage other and unspecified eating disorders, the best approach is to match the clinical presentation to one for which a treatment is indicated, and to treat with the respective first line psychotherapy and/or pharmacotherapy, until new evidence emerges (14). Night eating syndrome is a recently described presentation. Selective serotonin reuptake inhibitors have shown promise for night eating syndrome in two RCTs, but these also indicate a strong placebo response (38). Night eating syndrome has not been the subject of any psychotherapy RCTs. CBT has been suggested as a candidate psychotherapy approach.

Children and Adolescents

Anorexia Nervosa

For young people with anorexia nervosa, a specific type of family therapy known as family-based treatment (FBT) is recommended (13, 14) and is effective for approximately 50% of patients. No pharmacotherapy interventions have proved efficacious. FBT consists of 20 sessions provided over 6 months, and is detailed in a treatment manual (39). In the treatment, parents are considered the best resources for their child’s recovery and are urged to take an active role in treatment. Treatment has three phases including: 1) parents taking charge of child refeeding and weight gain; 2) transitioning control over eating back to the child in a developmentally appropriate way; and 3) establishing a healthy relationship with parents and addressing developmental issues problematic to the young person.

FBT is the most well-evaluated approach to other psychotherapies, has some evidence of superiority to other psychotherapies and therefore forms the basis for clinical recommendations. Despite promise, the evidence is limited. Of the 11 treatment RCTs for anorexia nervosa in predominantly youth samples (11), nine examined family therapy, but only two compared family therapy to an alternative treatment (the remainder varied an aspect of family therapy delivery between the trial arms) (11). In the largest and most rigorous trial to date (40), there were no differences in remission between FBT and adolescent-focused psychotherapy (AFP) at treatment completion (42% versus 23%), but the proportion remitted in FBT was higher at 6-month (40% versus 18%) and 12-month follow-up (49% versus 23%). AFP, used as the comparison in the largest RCT, is an intervention approach that assists the adolescent in adaptively coping with emotions and developmental challenges. It is based in self-psychology and psychodynamic theory, and considers pathology as arising from unmet developmental needs. The intervention techniques do not target food, weight, or body image cognitions directly, but rather draw on a range of techniques (cognitive, mindfulness, interpersonal, and behavioral) to manage stressors that give rise to symptoms. The FBT evidence base attracts criticism by not yet using comparisons that might be considered reasonable alternatives (i.e., CBT and IPT).

Bulimia Nervosa and Binge Eating Disorder

For bulimia nervosa in adolescents, the research evidence and clinical guidance are sparse. The publication of clinical practice guidelines predates the accumulated RCT evidence. FBT modified for bulimia nervosa and CBT guided self-help appear to be reasonable options. FBT is time-limited and involves 20 sessions conducted over 6 months. The phases mirror those of FBT for anorexia nervosa, with slight differences. For example, in the first phase parents are empowered to disrupt binge eating, purging, dieting, and other unhealthy forms of weight control without the focus on refeeding. CBT-guided self-help can be delivered using the same manual used with adults (41). CBT focuses on the normalization of eating patterns to reduce binge eating and managing thoughts, feeling, and situations that serve as triggers for disordered eating behaviors. The completion of daily self-monitoring records and learning tools to challenge cognitive distortions are core components of treatment.

One RCT among adolescents with bulimia nervosa has been conducted. Significantly more patients treated with FBT compared with supportive psychotherapy were binge- and purge-abstinent at posttreatment (39% versus 18%) and at 6-month follow-up (29% versus 10%) (42). In one further relevant RCT, two-thirds of the overall sample had bulimia nervosa and the remainder had eating disorders not otherwise specified (43). The abstinence rate for CBT-guided self-help was significantly higher than for FBT at posttreatment (42% versus 25%), although the effects were the same at 6-month follow-up (52% versus 55%).

No clinical trials have been conducted aimed specifically at treating binge eating disorder in adolescents, although several have shown positive response in reducing binge eating behavior (4446). One trial is underway comparing CBT with a wait-list control for binge eating disorder in adolescents (47) and one integrating components of DBT, such as mindfulness and distress tolerance skills training, and CBT targeting loss of control eating in adolescents (48).

Other Eating Disorders

As for adults, the recommended approach is to use the treatment guidance for anorexia nervosa or bulimia nervosa, depending on which condition the eating disorder most resembles (14).

Questions and Controversy

Despite the existence of empirically supported treatments, it is important to be aware that there are wide ranges of outcomes—many fully successful and some quite chronic with multiple hospitalizations. For adults with anorexia nervosa, success at posttreatment is less than 25%, largely because of substantial drop out (17). For bulimia nervosa and binge eating disorder in adults, the symptom remission rate associated with the leading psychotherapies is around 50% (for those completing treatment) (22, 26). About half of the young people with anorexia nervosa treated with family-based treatment remit (40).

Few prognostic factors for treatment outcome have been reliably identified. For anorexia nervosa, a longer duration of illness and longer duration of treatment and/or need for inpatient hospitalization are associated with worse outcomes (49). Predictors of relapse have included a lower desired body weight and treatment at a generalist (rather than specialist) clinic (49). A wide range of dietary choices is also associated with positive prognosis in anorexia nervosa suggesting less rigidity associated with food intake (50). For bulimia nervosa, psychiatric comorbidity and comorbid symptom severity predict poorer outcomes, and as yet, not much is known about prognostic factors for binge eating disorder (49). Clearly, there is room for improvement of treatment outcomes and for understanding prognostic factors.

Treatment refusal among patients with anorexia nervosa is frequently encountered. Clinical decision-making in this context involves ethical and medico-legal considerations that vary from jurisdiction to jurisdiction. The vantage points are complex: on the one hand, compelling a person to treatment (i.e., through a compulsive treatment order or legal guardianship) deprives liberty and may violate confidentiality and privacy, yet it is typically a last resort to preserve life. There is a general consensus supporting the use of legal interventions if the eating disorder poses mortal danger (14). Engaging and retaining adults with anorexia nervosa in treatment is of primary importance, although challenging given that the core treatment goal (i.e., weight gain) is the outcome that they most fear.

A robust debate within the field pertains to the degree to which FBT has become accepted as the treatment of choice for anorexia nervosa in children and adolescents. A recent debate feature captures some of these viewpoints, which the reader may find worth exploring (51, 52).

Binge eating disorder is often associated with overweight and obesity, which leads to a question about the degree to which psychotherapy should incorporate weight loss or weight management strategies. The primary clinical outcome for binge eating disorder is binge abstinence, yet in the context of overweight and obesity, weight and BMI are important secondary outcomes. Weight losses with psychotherapy have been modest and variable, with BWL having a slightly larger effect than CBT (53). As patients are typically on the path of gaining weight prior to treatment (54), psychotherapy interventions appear to prevent additional weight gain at least in the short term (53, 54). There is no evidence substantiating the concern that moderate caloric restriction in BWL triggers binge eating (37). Although many individuals with binge eating disorder seek weight loss as a therapeutic goal, others believe that a lifelong focus on weight loss has contributed to and perpetuated their disorder, and contend that a therapeutic focus on decreasing weight stigma and healthy lifestyles is preferred (55).

As new technologies develop and the Internet grows, technology is increasingly being used to enhance the delivery, accessibility, and cost-effectiveness of psychotherapy (56). Internet-based therapies for eating disorders, virtual reality-based treatments, telemedicine, and smartphone applications (e.g., self-monitoring records), are examples of current applications in either research or practice. Benefits are foreseeable for individuals or health professionals with limited access to specialists, or when treatment experience can be enhanced by technology integration, such as making homework more convenient and reducing stigma around treatment-seeking.

Recommendations from the Authors

A physician should always be part of the treatment team to manage general medical issues related to an eating disorder, and pharmacotherapy may play a crucial role in some presentations, delivered by a primary care practitioner or psychiatrist when more severe or recalcitrant pathology and/or psychiatric comorbidity are present (13, 14). The preferred setting for psychotherapy is the least restrictive setting, to reduce disruption to the patient’s family, social, academic, and work activities. However, clinical deterioration should raise attention to the need for a higher level of care.

Currently, for adults with anorexia nervosa, there is no clear evidence for the efficacy of any approach, and reasonable choices include CBT, IPT, cognitive analytic therapy, or supportive interventions such as specialist supportive clinical management—bearing in mind that psychotherapy may be optimally effective after renourishment is well underway and that supportive therapy may be optimal in the underweight state. For bulimia nervosa and binge eating disorder, CBT and/or antidepressant medication are considered to be first line treatments, and IPT and DBT (and BWL for binge eating disorder) are acceptable second line approaches. For anorexia nervosa in young people, FBT or family interventions that specifically target the eating disorder are appropriate.

Beyond the specific components of the interventions, the therapeutic stance should balance empathy and therapeutic firmness. Many eating disorder behaviors are perplexing, for instance, intense and seemingly irrational anxiety regarding forbidden foods and secrecy and deception regarding binge eating. Clinicians should guard against their own preconceptions and misperceptions. It is helpful to understand the ambivalence and fears the patient holds regarding recovery, and to reframe treatment resistance as part of the illness, not part of the individual (57). Working with people with eating disorders can be a very rewarding experience, despite being challenging at times, with treatment offering abundant prospects for the long-term physical and psychological health of these individuals. Additional resources are listed in Figure 1.

Figure 1.

Figure 1. Further Resources

Address correspondence to Dr. Cynthia Bulik, Department of Psychiatry, University of North Carolina at Chapel Hill, CB#7160, 101 Manning Drive, Chapel Hill, NC, 27599; e-mail:

Author Information and Disclosure

Hunna J. Watson, Ph.D., Department of Psychiatry, University of North Carolina at Chapel Hill, North Carolina, United States; Eating Disorders Program, Specialized Child and Adolescent Mental Health Service, Department of Health in Western Australia, Perth, Western Australia, Australia; School of Psychology and Speech Pathology, Curtin University, Perth, Western Australia, Australia; and School of Paediatrics and Child Health, The University of Western Australia, Perth, Western Australia, Australia

Cynthia M. Bulik, Ph.D., Department of Psychiatry, University of North Carolina at Chapel Hill; Department of Nutrition, University of North Carolina at Chapel Hill, North Carolina, United States; and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Dr. Watson reports no competing interests.

Dr. Bulik reports the following disclosure: Consultant: Shire Biopharmaceuticals.

Acknowledgments

We thank Karina Limburg, a research assistant at Princess Margaret Hospital for Children Eating Disorders Program, Perth, Western Australia, for collating and summarizing information used to prepare this manuscript.

References

1 American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC, American Psychiatric Association, 2000Google Scholar

2 Hudson JI, Hiripi E, Pope HG Jr, Kessler RC: The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 61:348–358CrossrefGoogle Scholar

3 Beck D, Casper R, Andersen A: Truly late onset of eating disorders: a study of 11 cases averaging 60 years of age at presentation. Int J Eat Disord 1996; 20:389–395CrossrefGoogle Scholar

4 Arcelus J, Mitchell AJ, Wales J, Nielsen S: Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry 2011; 68:724–731CrossrefGoogle Scholar

5 Bulik CM: Anxiety and depression in eating disorders, in Eating disorders and obesity: A comprehensive handbook. Edited by Brownell K. New York, Guilford Press, 2001, pp 193–198Google Scholar

6 American Psychiatric Association: Diagnostic and statistical manual of mental disorders (DSM-V), 5th ed, Washington, DC, American Psychiatric Association, 2013CrossrefGoogle Scholar

7 Kessler RC, Berglund PA, Chiu WT, et al.. (2013) The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Biol Psychiatry 73: 904–914.CrossrefGoogle Scholar

8 Johnson J, Spitzer R and Williams J. (2001) Health problems, impairment and illnesses associated with bulimia nervosa and binge eating disorder among primary care and obstetric gynaecology patients. Psychol Med 31: 1455–1466.CrossrefGoogle Scholar

9 Zipfel S, Reas DL, Thornton C, Olmsted MP, Williamson DA, Gerlinghoff M, Herzog W, Beumont PJ: Day hospitalization programs for eating disorders: a systematic review of the literature. Int J Eat Disord 2002; 31:105–117CrossrefGoogle Scholar

10 American Psychiatric Association: Practice guideline for the treatment of patients with eating disorders, 3rd ed. Washington, DC, American Psychiatric Association, 2006Google Scholar

11 Watson HJ, Bulik CM: Update on the treatment of anorexia nervosa: review of clinical trials, practice guidelines and emerging interventions. Psychol Med 2013; 43:2477–2500CrossrefGoogle Scholar

12 Geist R, Heinmaa M, Stephens D, Davis R, Katzman DK: Comparison of family therapy and family group psychoeducation in adolescents with anorexia nervosa. Can J Psychiatry 2000; 45:173–178CrossrefGoogle Scholar

13 National Institute for Clinical Excellence: Eating disorders. Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. London, NHS, 2004Google Scholar

14 American Psychiatric Association Work Group on Eating Disorders: Practice guideline for the treatment of patients with eating disorders (revision). Am J Psychiatry 2000; 157(Suppl):1–39CrossrefGoogle Scholar

15 Zipfel S, Wild B, Groß G, Friederich H-C, Teufel M, Schellberg D, Giel KE, de Zwaan M, Dinkel A, Herpertz S, Burgmer M, Löwe B, Tagay S, von Wietersheim J, Zeeck A, Schade-Brittinger C, Schauenburg H, Herzog W; ANTOP study group: Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial. Lancet 2014; 383:127–137CrossrefGoogle Scholar

16 Carter FA, Jordan J, McIntosh VV, Luty SE, McKenzie JM, Frampton CM, Bulik CM, Joyce PR: The long-term efficacy of three psychotherapies for anorexia nervosa: a randomized, controlled trial. Int J Eat Disord 2011; 44:647–654CrossrefGoogle Scholar

17 McIntosh VV, Jordan J, Carter FA, Luty SE, McKenzie JM, Bulik CM, Frampton CM, Joyce PR: Three psychotherapies for anorexia nervosa: a randomized, controlled trial. Am J Psychiatry 2005; 162:741–747CrossrefGoogle Scholar

18 Fairburn C, Marcus M, Wilson G: Cognitive-behavioral therapy for binge-eating: a comprehensive treatment manual, in Binge eating: Nature, assessment and treatment. Edited by Fairburn CG, Wilson GT. New York, Guilford Press, 1993, pp 361–404Google Scholar

19 Carter JC, Fairburn CG: Cognitive-behavioral self-help for binge eating disorder: a controlled effectiveness study. J Consult Clin Psychol 1998; 66:616–623CrossrefGoogle Scholar

20 Hay PP, Bacaltchuk J, Stefano S, Kashyap P: Psychological treatments for bulimia nervosa and binging. Cochrane Database Syst Rev 2009; (4):CD000562Google Scholar

21 Shapiro JR, Berkman ND, Brownley KA, Sedway JA, Lohr KN, Bulik CM: Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007; 40:321–336CrossrefGoogle Scholar

22 Wilson GT: Treatment of bulimia nervosa: when CBT fails. Behav Res Ther 1996; 34:197–212CrossrefGoogle Scholar

23 Fluoxetine Bulimia Nervosa Collaborative Study Group: Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992; 49:139–147CrossrefGoogle Scholar

24 Von Ranson KM, Farstad SM: Self-help approaches in the treatment of eating disorders, substance use disorders, and addictions, in Eating disorders, addictions, and substance use disorders: research, clinical and treatment perspectives. Edited by Brewerton TD, Dennis AB, Berlin, Springer-Verlag, 2014, pp 587–608CrossrefGoogle Scholar

25 Brownley KA, Berkman ND, Sedway JA, Lohr KN, Bulik CM: Binge eating disorder treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007; 40:337–348CrossrefGoogle Scholar

26 Hay P: A systematic review of evidence for psychological treatments in eating disorders: 2005-2012. Int J Eat Disord 2013; 46:462–469CrossrefGoogle Scholar

27 Fairburn CG: Cognitive behavior therapy and eating disorders. New York, Guilford Press, 2008Google Scholar

28 Fairburn CG, Jones R, Peveler RC, Carr SJ, Solomon RA, O’Connor ME, Burton J, Hope RA: Three psychological treatments for bulimia nervosa. A comparative trial. Arch Gen Psychiatry 1991; 48:463–469CrossrefGoogle Scholar

29 Wilfley DE, Agras WS, Telch CF, Rossiter EM, Schneider JA, Cole AG, Sifford LA, Raeburn SD: Group cognitive-behavioral therapy and group interpersonal psychotherapy for the nonpurging bulimic individual: a controlled comparison. J Consult Clin Psychol 1993; 61:296–305CrossrefGoogle Scholar

30 Agras WS, Walsh T, Fairburn CG, Wilson GT, Kraemer HC: A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Arch Gen Psychiatry 2000; 57:459–466CrossrefGoogle Scholar

31 Linehan M: Skills training manual for treating borderline personality disorder. New York, Guilford Press, 1993, 563 ppGoogle Scholar

32 Linehan M: Cognitive-behavioral treatment of borderline personality disorder. New York, Guilford Press, 1993, 563 ppGoogle Scholar

33 Safer DL, Telch CF, Chen EY: Dialectical behavior therapy for binge eating and bulimia. New York, Guilford Press, 2009Google Scholar

34 Telch CF, Agras WS, Linehan MM: Dialectical behavior therapy for binge eating disorder. J Consult Clin Psychol 2001; 69:1061–1065CrossrefGoogle Scholar

35 Safer DL, Robinson AH, Jo B: Outcome from a randomized controlled trial of group therapy for binge eating disorder: comparing dialectical behavior therapy adapted for binge eating to an active comparison group therapy. Behav Ther 2010; 41:106–120CrossrefGoogle Scholar

36 Womble LG, Wadden TA, McGuckin BG, Sargent SL, Rothman RA, Krauthamer-Ewing ES: A randomized controlled trial of a commercial internet weight loss program. Obes Res 2004; 12:1011–1018CrossrefGoogle Scholar

37 Wilson GT: Treatment of binge eating disorder. Psychiatr Clin North Am 2011; 34:773–783CrossrefGoogle Scholar

38 Vander Wal JS: The treatment of night eating syndrome: a review and theoretical model. Curr Obes Rep 2014; 3:137–144CrossrefGoogle Scholar

39 Lock J, Le Grange D, Agras W, Dare C: Treatment manual for anorexia nervosa: a family-based approach. New York, Guilford Press, 2001Google Scholar

40 Lock J, Le Grange D, Agras WS, Moye A, Bryson SW, Jo B: Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa. Arch Gen Psychiatry 2010; 67:1025–1032CrossrefGoogle Scholar

41 Fairburn CG: Overcoming binge eating. New York, Guilford, 1995Google Scholar

42 le Grange D, Crosby RD, Rathouz PJ, Leventhal BL: A randomized controlled comparison of family-based treatment and supportive psychotherapy for adolescent bulimia nervosa. Arch Gen Psychiatry 2007; 64:1049–1056CrossrefGoogle Scholar

43 Schmidt U, Lee S, Beecham J, Perkins S, Treasure J, Yi I, Winn S, Robinson P, Murphy R, Keville S, Johnson-Sabine E, Jenkins M, Frost S, Dodge L, Berelowitz M, Eisler I: A randomized controlled trial of family therapy and cognitive behavior therapy guided self-care for adolescents with bulimia nervosa and related disorders. Am J Psychiatry 2007; 164:591–598CrossrefGoogle Scholar

44 Debar LL, Wilson GT, Yarborough BJ, Burns B, Oyler B, Hildebrandt T, Clarke GN, Dickerson J, Striegel RH: Cognitive behavioral treatment for recurrent binge eating in adolescent girls: a pilot trial. Cognit Behav Pract 2013; 20:147–161CrossrefGoogle Scholar

45 Jones M, Luce KH, Osborne MI, Taylor K, Cunning D, Doyle AC, Wilfley DE, Taylor CB: Randomized, controlled trial of an Internet-facilitated intervention for reducing binge eating and overweight in adolescents. Pediatrics 2008; 121:453–462CrossrefGoogle Scholar

46 Tanofsky-Kraff M, Wilfley DE, Young JF, Mufson L, Yanovski SZ, Glasofer DR, Salaita CG, Schvey NA: A pilot study of interpersonal psychotherapy for preventing excess weight gain in adolescent girls at-risk for obesity. Int J Eat Disord 2010; 43:701–706CrossrefGoogle Scholar

47 Hilbert A: Cognitive-behavioral therapy for binge eating disorder in adolescents: study protocol for a randomized controlled trial. Trials 2013; 14:312CrossrefGoogle Scholar

48 Mazzeo SE, Kelly NR, Stern M, Palmberg AA, Belgrave FZ, Tanofsky-Kraff M, Latzer Y, Bulik CM: LIBER8 design and methods: an integrative intervention for loss of control eating among African American and White adolescent girls. Contemp Clin Trials 2013; 34:174–185CrossrefGoogle Scholar

49 Keel PK, Brown TA: Update on course and outcome in eating disorders. Int J Eat Disord 2010; 43:195–204Google Scholar

50 Schebendach JE, Mayer LE, Devlin MJ, Attia E, Contento IR, Wolf RL, Walsh BT: Food choice and diet variety in weight-restored patients with anorexia nervosa. J Am Diet Assoc 2011; 111:732–736CrossrefGoogle Scholar

51 Strober M. Proposition: family based treatment is overvalued. Position: proposer in Advances in eating disorders: theory, research and practice. New York, Routledge, 2014, pp. 1–21Google Scholar

52 Lock J, Le Grange D: Proposition: family-based treatment is overvalued. Position: opposed in Advances in eating disorders: theory, research and practice. New York, Routledge, 2014, pp. 21–32Google Scholar

53 Grilo CM, Masheb RM, Wilson GT, Gueorguieva R, White MA: Cognitive-behavioral therapy, behavioral weight loss, and sequential treatment for obese patients with binge-eating disorder: a randomized controlled trial. J Consult Clin Psychol 2011; 79:675–685CrossrefGoogle Scholar

54 Masheb RM, White MA, Grilo CM: Substantial weight gains are common prior to treatment-seeking in obese patients with binge eating disorder. Compr Psychiatry 2013; 54:880–884CrossrefGoogle Scholar

55 Bacon L, Aphramor L: Weight science: evaluating the evidence for a paradigm shift. Nutr J 2011; 10:9CrossrefGoogle Scholar

56 Shingleton RM, Richards LK, Thompson-Brenner H: Using technology within the treatment of eating disorders: a clinical practice review. Psychotherapy (Chic) 2013; 50:576–582CrossrefGoogle Scholar

57 Vitousek K, Watson S, Wilson GT: Enhancing motivation for change in treatment-resistant eating disorders. Clin Psychol Rev 1998; 18:391–420CrossrefGoogle Scholar